Marvin Hausman

Marvin Hausman

Director Ejecutivo en LUDWIG ENTERPRISES, INC. .

Fortuna: 10 M $ al 31/05/2024

82 años
Health Technology
Commercial Services
Consumer Services

Perfil

Marvin S.
Hausman
was the founder of Axonyx, Inc. (founded in 1997), where he served as Chairman, President & Chief Executive Officer until 2006.
He was also the founder of Entia Biosciences, Inc. (founded in 2007), where he held the titles of Chairman, CFO, CTO & Chief Scientific Officer in 2015.
Additionally, Dr. Hausman founded Northwest Medical Research Partners, Inc. in 1995 and currently serves as President.
Dr. Hausman is also the founder of King Pharmaceuticals Research & Development, Inc. (founded in [YEAR]).
Dr. Hausman's current job(s) include being the CEO, Chief Science Officer & Director at Ludwig Enterprises, Inc. since 2023, Chairman & Chief Executive Officer at Total Nutraceutical Solutions, Inc. since 2008, Chairman at Pilz Biosciences Corp., and Independent Director at NuGenerex Immuno-Oncology, Inc.Dr. Hausman's former job(s) include being the Chairman, President & Chief Executive Officer at GT Biopharma, Inc. from 2004 to 2008, Chairman & Chief Executive Officer at W World Corp., Director at GT Biopharma, Inc. in 2002 and 2003, Director at Regent Assisted Living, Inc. from 1996 to 2001, Director at Arbios Systems, Inc., Director at Arbios Technologies, Inc. from 2003 to 2005, and Director at TorreyPines Therapeutics, Inc. from 1996 to 2007.
He was also a Member of the American Medical Association, Member-Governors Board at New York University from 1992 to 1998, Research Associate at the National Institutes of Health, and a Member of various scientific and medical associations.
Dr. Hausman's education includes an undergraduate degree from Brooklyn College in 1963 and a doctorate degree from New York University School of Medicine in 1967.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/04/2024 44 500 000 ( 27.98% ) 9 M $ 31/05/2024
16/04/2024 2 000 000 ( 28.57% ) 420 000 $ 31/05/2024
08/05/2017 14 625 ( 9.72% ) 29 $ 31/12/2021

Cargos activos de Marvin Hausman

EmpresasCargoInicio
NUGENEREX IMMUNO-ONCOLOGY, INC. Director/Miembro de la Junta -
LUDWIG ENTERPRISES, INC. Director Ejecutivo 16/11/2023
Presidente -
Director Ejecutivo 01/10/2008
Northwest Medical Research Partners, Inc. Fundador 01/10/1995
Todos los cargos activos de Marvin Hausman

Antiguos cargos conocidos de Marvin Hausman.

EmpresasCargoFin
IOVANCE BIOTHERAPEUTICS, INC. Director Técnico/Científico/I+D 26/09/2013
GT BIOPHARMA, INC. Director Financiero/CFO -
Director/Miembro de la Junta 23/05/2007
Director Ejecutivo 06/10/2006
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Marvin Hausman.

Formación de Marvin Hausman.

Brooklyn College Undergraduate Degree
New York University School of Medicine Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Marvin Hausman.

Relaciones

100 +

Relaciones de 1er grado

30

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas5
GT BIOPHARMA, INC.

Health Technology

W WORL

Health Technology

ENTIA BIOSCIENCES, INC.

Health Technology

LUDWIG ENTERPRISES, INC.

Finance

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

Empresas privadas21
King Pharmaceuticals Research & Development, Inc.

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Government

Health Technology

Commercial Services

Commercial Services

Commercial Services

American Federation for Medical Research

The American Association of Immunologists

Northwest Medical Research Partners, Inc.

Commercial Services

Commercial Services

American Board of Urology

Association for Academic Surgery

Health Technology

Health Technology

Ver las conexiones de la empresa